Impact of Depressive Mood on Relapse in Patients with Inflammatory Bowel Disease: A Prospective 18-Month Follow-Up Study

Psychosomatic Medicine

Volumn 66, Issue 1, 2004, Pages 79-84

  Mittermaier, Christian ^a   Dejaco, Clemens ^a   Waldhoer, Thomas ^b   Oefferlbauer Ernst, Anna ^a   Miehsler, Wolfgang ^a   Beier, Markus ^a   Tillinger, Wolfgang ^a   Gangl, Alfred ^a   Moser, Gabriell ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anxiety; Depressive mood; Disease activity; Health related quality of life; Inflammatory bowel disease

Indexed keywords

ADULT; ANXIETY; ARTICLE; BECK DEPRESSION INVENTORY; CROHN DISEASE; DEPRESSION; DISEASE EXACERBATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; MOOD; PRIORITY JOURNAL; PSYCHOSOMATICS; QUALITY OF LIFE; RELAPSE; RISK FACTOR; ULCERATIVE COLITIS;

ADULT; AFFECT; COLITIS, ULCERATIVE; CROHN DISEASE; DEPRESSION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHOLOGICAL TESTS; QUALITY OF LIFE; RECURRENCE; SEVERITY OF ILLNESS INDEX;

EID: 0742270563     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PSY.0000106907.24881.F2     Document Type: Article

References (44)

1. Kordy H, Normann D. Psychological and somatic factors in the disease course of Crohn disease. Psychother Psychosom Med Psychol 1992;42:141-9.
2. Andrews H, Barczak P, Allan RN. Psychiatric illness in patients with inflammatory bowel disease. Gut 1987;28:1600-4.
3. Greene BR, Blanchard EB, Wan CK. Long-term monitoring of psychosocial stress and symptomatology in inflammatory bowel disease. Behav Res Ther 1994;32:217-26.
4. Porcelli P, Leoci C, Guerra V. A prospective study of the relationship between disease activity and psychologic distress levels in patients with inflammatory bowel disease. Scand J Gastroenterol 1996;31:792-6.
5. Drossman DA. Psychosocial factors in ulcerative colitis and Crohn's disease. In: Kirsner JB, Shorter RG, eds. 4th ed. Inflammatory Bowel Disease. Baltimore, MD: Williams & Wilkins; 1995:492-513.
6. McKegney FP, Gordon RO, Levine SM. A psychosomatic comparison of patients with ulcerative colitis and Crohn's disease. Psychosom Med 1970;32:153-66.
7. Levenstein S, Prantera C, Varvo V, Scribano ML, Berto E, Andreoli A, Luzi C. Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am J Gastroenterol 1994;89:1219-25.
8. Levenstein S, Prantera C, Varvo V, Scribano ML, Andreoli A, Luzi C, Arca M, Berto E, Milite G, Marcheggiano A. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol 2000;95:1213-20.
9. Duffy LC, Zielezny MA, Marshall JR, Byers TE, Weiser MM, Phillips JF, Calkins BM, Ogra PL, Graham S. Relevance of major stress events as an indicator of disease activity prevalence in inflammatory bowel disease. Behav Med 1991;17:101-10.
10. Riley SA, Mani V, Goodman MJ, Lucas S. Why do patients with ulcerative colitis relapse? Gut 1990;31:179-83.
11. Moser G, Maier-Dobersberger TH, Vogelsang H, Lochs H. Inflammatory bowel disease (IBD): patients' beliefs about the etiology of their disease - a controlled study. Psychosom Med 1993;55:A131.
12. Robertson DAF, Ray J, Diamond I, Edwards JG. Personality profile and affective state of patients with inflammatory bowel disease. Gut 1989;30:623-6.
13. Carney RM, Rich MW, Freedland KE, Saini J, teVelde A, Simeone C, Clark K. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988;50:627-33.
14. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995;91:999-1005.
15. Watson M, Haviland JS, Greer S, Davidson J, Bliss JM. Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 1999;354:1331-6.
16. Rodin G, Craven J, Littlefield C. Depression in the Medically III: An Integrated Approach. New York: Brunner/Mazel; 1991.
17. McFarlane AC, Brooks PM. An analysis of the relationship between psychological morbidity and disease activity in rheumatoid arthritis. J Rheumatol 1988;15:926-31.
18. Fifield J, Tennen H, Reisine S, McQuillan J. Depression and the long-term risk of pain, fatigue, and disability in patients with rheumatoid arthritis. Arthritis Rheum 1998;41:1851-7.
19. Lustman PJ, Griffith LS, Freedland KE, Clouse RE. The course of major depression in diabetes. Gen Hosp Psychiatry 1997;19:138-43.
20. Best WR, Bechtel JM, Singleton JWW, Kern FJ. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
21. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989;289:82-6.
22. Stange EF, Schreiber S, Raedler A, Stallmach A, Scholmerich J, Loeschke K, Starlinger M, Fischbach W, Caspary WF. Therapy of Crohn diseases - results of a Consensus Conference of the German Society of Digestive and Metabolic Diseases. Z Gastroenterol 1997;35:541-54.
23. Stange EF, Riemann J, von Herbay A, Lochs H, Fleig WE, Scholmerich J, Kruis W, Porschen R, Bruch HP, Zeitz M, Schreiber S, Moser G, Matthes H, Selbmann HK, Goebell H, Caspary WF. Diagnosis and therapy of ulcerative colitis - results of an evidence-based Consensus Conference of the German Society of Digestive and Metabolic Diseases. Z Gastroenterol 2001;39:19-20.
24. Sandbom WJ, Feagan BG, Hanauer SB, Lochs H, Lofberg R, Modigliani R, Present DH, Rutgeerts P, Scholmerich J, Stange EF, Sutherland LR. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002;122:512-30.
25. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-29.
26. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:53-63.
27. Lustman PJ, Clouse RE, Griffith LS, Carney RM, Freedland KE. Screening for depression in diabetes using the Beck Depression Inventory. Psychosom Med 1997;59:24-31.
28. Spielberger C, Gorsuch R, Lushene R. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1970.
29. Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, Tompkins C. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989;96:804-10.
30. Levenstein S, Prantera C, Varvo V, Scribano ML, Berto E, Luzi C, Andreoli A. Development of the Perceived Stress Questionnaire: a new tool for psychosomatic research. J Psychosom Res 1993;37:19-32.
31. Drossman DA, Leserman J, Li ZM, Mitchell CM, Zagami EA, Patrick DL. The rating form of IBD patient concerns: a new measure of health status. Psychosom Med 1991;53:701-12.
32. Dorda W, Laminger B, Reichetseder Ch, Sachs P. Computereinsatz zur Analyse medizinischer Daten - Die Auswertungssysteme WAMAS und WAMASTAT. In Grabner, ed. WAMIS Wiener Allgemeines Medizinisches Informations-System. Berlin-Heidelberg-New York-Tokyo: Springer Verlag; 1985:251-91.
33. Addolorato G, Stefanini GF, Capristo E, Caputo F, Gasbarrini A, Gasbarrini G. Anxiety and depression in adult untreated celiac subjects and in patients affected by inflammatory bowel disease: a personality "trait" or a reactive illness? Hepatogastroenterology 1996;43:1513-7.
34. Addolorato G, Capristo E, Stefanini GF, Gasbarrini G. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol 1997;32:1013-21.
35. Kurina LM, Goldacrem MJ, Yeates D, Gill LE. Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Commun Health 2001;55:716-20.
36. Van Hemert AM, Hengeveld MW, Bolk JH, Rooijmans HG, Vandenbroucke JP. Psychiatric disorders in relation to medical illness among patients of a general medical out-patient clinic. Psychol Med 1993;23:167-73.
37. North CS, Alpers DH, Helzer JE, Spitznagel EL, Clouse RE. Do life events or depression exacerbate inflammatory bowel disease? a prospective study. Ann Intern Med 1991;114:381-6.
38. Cleeland CS, Demetri GD, Glaspy J, Cella DF, Portenoy RK, Cremieux P, Itri LM. Identifying hemoglobin level for optimal quality of life: results of an incremental analysis. Proc Am Soc Clin Oncol 1999;18:A2215.
39. Gasche C, Dejaco C, Waldhoer T, Tillinger W, Reinisch W, Fueger GF, Gangl A, Lochs H. Intravenous iron and erythropoietin for anemia associated with Crohn disease: a randomized, controlled trial. Ann Intern Med 1997;126:782-7.
40. Stein M. Stress, depression, and the immune system. J Clin Psychiatry 1989;50:35-40.
41. Herbert TB, Cohen S. Depression and immunity: a meta-analytic review. Psychol Bull 1993;113:472-86.
42. Rief W, Pilger F, Ihle D, Bosmans E, Egyed B, Maes M. Immunological differences between patients with major depression and somatization syndrome. Psychiatry Res 2001;105:165-74.
43. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol 2002;20:495-549.
44. Rose M, Hildebrandt M, Fliege H, Seibold S, Mönnikes H, Klapp BF. T-cell immune parameters and depression in patients with Crohn's disease. J Clin Gastroenterol 2002;34:40-8.